(9-245) Bleeding Risk among Cancer Patients Receiving Concurrent CYP-Interacting Tyrosine Kinase Inhibitors with Direct Oral Anticoagulants versus Alternative Anticoagulation Therapies
Wednesday, December 6, 2023
8:30 AM - 9:30 AM
Location: Hall E, Lower Level
Co-Author(s): Kelly Shepard, Danielle Fry, Alexander Levine